339 related articles for article (PubMed ID: 27296152)
1. Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System.
Norris C; Loureiro M; Kramar C; Zunder J; Renard J; Rushlow W; Laviolette SR
Neuropsychopharmacology; 2016 Nov; 41(12):2839-2850. PubMed ID: 27296152
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway.
Renard J; Loureiro M; Rosen LG; Zunder J; de Oliveira C; Schmid S; Rushlow WJ; Laviolette SR
J Neurosci; 2016 May; 36(18):5160-9. PubMed ID: 27147666
[TBL] [Abstract][Full Text] [Related]
3. Delta-9-tetrahydrocannabinol potentiates fear memory salience through functional modulation of mesolimbic dopaminergic activity states.
Fitoussi A; Zunder J; Tan H; Laviolette SR
Eur J Neurosci; 2018 Jun; 47(11):1385-1400. PubMed ID: 29776015
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid transmission in the prefrontal cortex bi-phasically controls emotional memory formation via functional interactions with the ventral tegmental area.
Draycott B; Loureiro M; Ahmad T; Tan H; Zunder J; Laviolette SR
J Neurosci; 2014 Sep; 34(39):13096-109. PubMed ID: 25253856
[TBL] [Abstract][Full Text] [Related]
5. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal cannabinoid transmission modulates dopamine neuron activity: impact on rewarding memory formation and social interaction.
Loureiro M; Renard J; Zunder J; Laviolette SR
Neuropsychopharmacology; 2015 May; 40(6):1436-47. PubMed ID: 25510937
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
Hudson R; Renard J; Norris C; Rushlow WJ; Laviolette SR
J Neurosci; 2019 Oct; 39(44):8762-8777. PubMed ID: 31570536
[TBL] [Abstract][Full Text] [Related]
8. Interactions between cannabidiol and Δ
Todd SM; Zhou C; Clarke DJ; Chohan TW; Bahceci D; Arnold JC
Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience.
Loureiro M; Kramar C; Renard J; Rosen LG; Laviolette SR
Biol Psychiatry; 2016 Aug; 80(3):216-25. PubMed ID: 26681496
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors.
Gomes FV; Reis DG; Alves FH; Corrêa FM; Guimarães FS; Resstel LB
J Psychopharmacol; 2012 Jan; 26(1):104-13. PubMed ID: 21148020
[TBL] [Abstract][Full Text] [Related]
11. Involvement of 5-HT1B receptors within the ventral tegmental area in ethanol-induced increases in mesolimbic dopaminergic transmission.
Yan QS; Zheng SZ; Feng MJ; Yan SE
Brain Res; 2005 Oct; 1060(1-2):126-37. PubMed ID: 16212943
[TBL] [Abstract][Full Text] [Related]
12. Involvement of 5-HT1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis.
Yan QS; Zheng SZ; Yan SE
Brain Res; 2004 Sep; 1021(1):82-91. PubMed ID: 15328035
[TBL] [Abstract][Full Text] [Related]
13. Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: contribution of 5HT₁A receptors and stressful experiences.
Marinho AL; Vila-Verde C; Fogaça MV; Guimarães FS
Behav Brain Res; 2015 Jun; 286():49-56. PubMed ID: 25701682
[TBL] [Abstract][Full Text] [Related]
14. Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effects.
Tan H; Bishop SF; Lauzon NM; Sun N; Laviolette SR
Neuropharmacology; 2009 Mar; 56(4):741-51. PubMed ID: 19133278
[TBL] [Abstract][Full Text] [Related]
15. NMDA receptor blockade in the prelimbic cortex activates the mesolimbic system and dopamine-dependent opiate reward signaling.
Tan H; Rosen LG; Ng GA; Rushlow WJ; Laviolette SR;
Psychopharmacology (Berl); 2014 Dec; 231(24):4669-79. PubMed ID: 24871699
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor blockade modulates the rewarding and aversive properties of nicotine via dissociable neuronal activity patterns in the nucleus accumbens.
Sun N; Laviolette SR;
Neuropsychopharmacology; 2014 Nov; 39(12):2799-815. PubMed ID: 24896614
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 receptors modulate the expression of contextual conditioned fear: role of the ventral tegmental area and the basolateral amygdala.
de Souza Caetano KA; de Oliveira AR; Brandão ML
Behav Pharmacol; 2013 Aug; 24(4):264-74. PubMed ID: 23751519
[TBL] [Abstract][Full Text] [Related]
18. Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors.
Navailles S; Moison D; Ryczko D; Spampinato U
J Neurochem; 2006 Nov; 99(4):1311-9. PubMed ID: 17018023
[TBL] [Abstract][Full Text] [Related]
19. Inputs from the basolateral amygdala to the nucleus accumbens shell control opiate reward magnitude via differential dopamine D1 or D2 receptor transmission.
Lintas A; Chi N; Lauzon NM; Bishop SF; Sun N; Tan H; Laviolette SR
Eur J Neurosci; 2012 Jan; 35(2):279-90. PubMed ID: 22236063
[TBL] [Abstract][Full Text] [Related]
20. Selective post-training time window for memory consolidation interference of cannabidiol into the prefrontal cortex: Reduced dopaminergic modulation and immediate gene expression in limbic circuits.
Rossignoli MT; Lopes-Aguiar C; Ruggiero RN; Do Val da Silva RA; Bueno-Junior LS; Kandratavicius L; Peixoto-Santos JE; Crippa JA; Cecilio Hallak JE; Zuardi AW; Szawka RE; Anselmo-Franci J; Leite JP; Romcy-Pereira RN
Neuroscience; 2017 May; 350():85-93. PubMed ID: 28344069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
